Abil Chempharma Private Limited, a active private limited company, was established on 18 September 2002 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the trade sector, it holds CIN: U51397MH2002PTC137264. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.73 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Sanket Jatin Gandhi (Director), Tejas Champaklal Shah (Director). Past directors included Nirav Vikram Maniar, Sanket Jatin Gandhi, Vikram Vadilal Maniar. It holds ₹67.00 Cr open charges and ₹79.07 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1701, 17Th Floor, B-Wing, Lotus Corporate Park, Graham Firth Steel Comp.,We Highway,Gore, Goan East, Mumbai, Maharashtra, 400063.
U51397MH2002PTC137264
137264
18 September 2002
₹1.00 Cr
₹2.73 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Abil Chempharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanket Jatin Gandhi | Director | 21 Aug 2023 | Current |
| Tejas Champaklal Shah | Director | 01 Dec 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 21 Jul 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 09 Nov 2013 | Past |
| Pramod Abcsdd | Director | 21 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abil Chempharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.46% increase. The company also saw a substantial fall in profitability, with a 31.14% decrease in profit. The company's net worth Soared by an impressive increase of 19.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Abil Chempharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹670,000,000.00
₹790,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2025 | Axis Bank Limited | ₹22.00 Cr | Open |
| 20 Jul 2018 | Axis Bank Limited | ₹45.00 Cr | Open |
| 25 Nov 2022 | Others | ₹12.50 Cr | Satisfied |
| 30 Oct 2021 | State Bank Of India | ₹4.95 Cr | Satisfied |
| 03 Mar 2021 | Others | ₹5.62 Cr | Satisfied |
Explore comprehensive loan charge details -
Abil Chempharma has a workforce of 3 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Abil Chempharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abil Chempharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Axis Bank Limited amounted to Rs. 22.00 Cr with Charge ID 101151892 was registered on 30 Aug 2025. was completed.
The activity A charge with Axis Bank Limited of Rs. 45.00 Cr registered on 20 Jul 2018 with Charge ID 100212496 was modified on 22 Apr 2025. was completed.
Progress on A charge registered on 09 Mar 2018 via Charge ID 100170714 with Axis Bank Limited was fully satisfied on 22 Apr 2025. was documented.
A charge registered on 25 Nov 2022 via Charge ID 100645273 with Others was fully satisfied on 28 Nov 2024. was recorded as a recent event.
Abil Chempharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Abil Chempharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The CIN of Abil Chempharma Private Limited is U51397MH2002PTC137264.
Abil Chempharma Private Limited is headquartered at 1701, 17Th Floor, B-Wing, Lotus Corporate Park, Graham Firth Steel Comp.,We Highway,Gore, Goan East, Mumbai, Maharashtra, 400063.
Abil Chempharma Private Limited was incorporated on 18 September 2002.
The current directors of Abil Chempharma Private Limited are
The primary industry of Abil Chempharma Private Limited is Trade.
Abil Chempharma Private Limited is unlisted.
The authorized capital of Abil Chempharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹2.73 M.
The compliance status of Abil Chempharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX